BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29789640)

  • 1. Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study.
    Chatterjee P; Goozee K; Lim CK; James I; Shen K; Jacobs KR; Sohrabi HR; Shah T; Asih PR; Dave P; ManYan C; Taddei K; Lovejoy DB; Chung R; Guillemin GJ; Martins RN
    Sci Rep; 2018 May; 8(1):8008. PubMed ID: 29789640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
    Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
    J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load.
    Goozee K; Chatterjee P; James I; Shen K; Sohrabi HR; Asih PR; Dave P; ManYan C; Taddei K; Ayton SJ; Garg ML; Kwok JB; Bush AI; Chung R; Magnussen JS; Martins RN
    Mol Psychiatry; 2018 Aug; 23(8):1807-1812. PubMed ID: 28696433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease.
    Goozee K; Chatterjee P; James I; Shen K; Sohrabi HR; Asih PR; Dave P; Ball B; ManYan C; Taddei K; Chung R; Garg ML; Martins RN
    Sci Rep; 2017 Apr; 7(1):676. PubMed ID: 28386119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.
    Chatterjee P; Mohammadi M; Goozee K; Shah TM; Sohrabi HR; Dias CB; Shen K; Asih PR; Dave P; Pedrini S; Ashton NJ; Hye A; Taddei K; Lovejoy DB; Zetterberg H; Blennow K; Martins RN
    J Alzheimers Dis; 2020; 76(1):291-301. PubMed ID: 32538848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.
    Chatterjee P; Goozee K; Sohrabi HR; Shen K; Shah T; Asih PR; Dave P; ManYan C; Taddei K; Chung R; Zetterberg H; Blennow K; Martins RN
    J Alzheimers Dis; 2018; 63(2):479-487. PubMed ID: 29630554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation.
    Rembach A; Watt AD; Wilson WJ; Rainey-Smith S; Ellis KA; Rowe CC; Villemagne VL; Macaulay SL; Bush AI; Martins RN; Ames D; Masters CL; Doecke JD;
    J Neuroimmunol; 2014 Aug; 273(1-2):65-71. PubMed ID: 24907904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease.
    Liang Y; Xie S; He Y; Xu M; Qiao X; Zhu Y; Wu W
    Dis Markers; 2022; 2022():9484217. PubMed ID: 35096208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenine and its metabolites in Alzheimer's disease patients.
    Gulaj E; Pawlak K; Bien B; Pawlak D
    Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenine Pathway Metabolites in Alzheimer's Disease.
    Giil LM; Midttun Ø; Refsum H; Ulvik A; Advani R; Smith AD; Ueland PM
    J Alzheimers Dis; 2017; 60(2):495-504. PubMed ID: 28869479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression.
    Lim CK; Bilgin A; Lovejoy DB; Tan V; Bustamante S; Taylor BV; Bessede A; Brew BJ; Guillemin GJ
    Sci Rep; 2017 Feb; 7():41473. PubMed ID: 28155867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
    Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
    JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
    Rembach A; Watt AD; Wilson WJ; Villemagne VL; Burnham SC; Ellis KA; Maruff P; Ames D; Rowe CC; Macaulay SL; Bush AI; Martins RN; Masters CL; Doecke JD;
    J Alzheimers Dis; 2014; 40(1):95-104. PubMed ID: 24334723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease.
    Guillemin GJ; Brew BJ
    Redox Rep; 2002; 7(4):199-206. PubMed ID: 12396664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
    Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
    Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
    Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
    Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-β and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer's Disease.
    Santos CY; Lim YY; Wu WC; Machan JT; Polynice S; Schindler R; Maruff P; Snyder PJ
    J Alzheimers Dis; 2016; 50(1):127-31. PubMed ID: 26639961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.